Napean Trading & Investment Co Singapore PTE Ltd reduced its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 11.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 29,818 shares of the semiconductor company’s stock after selling 3,920 shares during the quarter. Synopsys makes up 2.7% of Napean Trading & Investment Co Singapore PTE Ltd’s portfolio, making the stock its 9th largest holding. Napean Trading & Investment Co Singapore PTE Ltd’s holdings in Synopsys were worth $14,006,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nicholas Investment Partners LP lifted its holdings in shares of Synopsys by 1.3% during the fourth quarter. Nicholas Investment Partners LP now owns 11,845 shares of the semiconductor company’s stock valued at $5,564,000 after acquiring an additional 155 shares during the period. Fifth Lane Capital LP bought a new position in shares of Synopsys during the fourth quarter valued at $235,000. Focus Partners Wealth lifted its holdings in shares of Synopsys by 44.2% during the fourth quarter. Focus Partners Wealth now owns 55,898 shares of the semiconductor company’s stock valued at $26,267,000 after acquiring an additional 17,121 shares during the period. Graybill Wealth Management LTD. lifted its holdings in shares of Synopsys by 0.3% during the fourth quarter. Graybill Wealth Management LTD. now owns 15,345 shares of the semiconductor company’s stock valued at $7,208,000 after acquiring an additional 44 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of Synopsys by 6.1% during the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 64,227 shares of the semiconductor company’s stock valued at $30,169,000 after acquiring an additional 3,713 shares during the period. 85.47% of the stock is owned by institutional investors.
Analyst Ratings Changes
SNPS has been the subject of a number of analyst reports. Morgan Stanley lifted their price objective on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Robert W. Baird set a $558.00 price objective on Synopsys in a report on Thursday, May 28th. Berenberg Bank set a $633.00 price target on Synopsys in a report on Wednesday, May 27th. Needham & Company LLC reaffirmed a “buy” rating and issued a $580.00 price target on shares of Synopsys in a report on Thursday, May 28th. Finally, BNP Paribas Exane lifted their price objective on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research report on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $563.81.
Synopsys Price Performance
Shares of SNPS stock opened at $453.89 on Friday. The stock has a 50-day moving average price of $473.57 and a 200 day moving average price of $460.43. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The firm has a market cap of $86.91 billion, a price-to-earnings ratio of 105.07, a PEG ratio of 2.67 and a beta of 1.22. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The firm had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company’s revenue was up 41.9% on a year-over-year basis. During the same period last year, the company earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
